Startup Stage: Project ⎢ TRL4 / CRL1
Value Proposition: A biotech platform to help healthcare innovators with limited access to high-quality peptide-target interaction data by generating structured, high-throughput datasets across diverse targets with a proprietary system that unlocks next-gen applications in drug discovery, enzymatic design, vaccines, and diagnostics
Product: Materials, Nano
Market: Health
IP: 3 Patents
Founders (ext.): Commercial, -- │ Technical, Cesar Pascual Garcia & Janwa El Maiss
Contact (int.): Research, Cesar Pascual Garcia │ Ventures, Alex Godlewski
Revenue: --
Funding: Grant (EIC) │ €3M raised in total
